CrossrefInfokarte
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis
Clinical Pharmacology: Advances and Applications · 2016-02 · 9
DOI: 10.2147/cpaa.s98221 ↗Abstract
Kein Abstract verfügbar.
EUVIMED